Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
2 Articles
2 Articles
Cybin Applauds FDA Commissioner Dr. Martin Makary's Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
– U.S. Food and Drug Administration (“FDA”) Commissioner identifies psychedelic drug development as a top agency priority in an effort to address unmet needs in men…
FDA’s Makary Hints at Faster Reviews for Psychedelic Therapies - Psychedelic Alpha
In a five-minute interview on NewsNation’s ‘On Balance’ show on Friday, FDA Commissioner Martin (‘Marty’) Makary fielded a few softball questions from host Jillian Michaels. After discussing Trump’s Surgeon General pick Casey Means—who Makary described as “a force of nature”—the pair dived into the topic of psychedelics. “PSYCHEDELIC THERAPY IN THE MAHA ERA”, the chyron at the bottom of the… Source
Coverage Details
Bias Distribution
- 100% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage